SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-18-012364
Filing Date
2018-08-20
Accepted
2018-08-20 16:55:11
Documents
58
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm 10-Q/A 632450
2 ex31-1.htm EX-31.1 19659
3 ex31-2.htm EX-31.2 11771
4 ex32-1.htm EX-32.1 8467
5 ex32-2.htm EX-32.2 8286
  Complete submission text file 0001493152-18-012364.txt   3529216

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE prph-20180331.xml EX-101.INS 533017
7 XBRL SCHEMA FILE prph-20180331.xsd EX-101.SCH 50300
8 XBRL CALCULATION FILE prph-20180331_cal.xml EX-101.CAL 64856
9 XBRL DEFINITION FILE prph-20180331_def.xml EX-101.DEF 165377
10 XBRL LABEL FILE prph-20180331_lab.xml EX-101.LAB 334954
11 XBRL PRESENTATION FILE prph-20180331_pre.xml EX-101.PRE 245246
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-21617 | Film No.: 181028724
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1